Sie sind auf Seite 1von 6

Panduan Abstrak

Topik abstrak meliputi semua aspek yang berhubungan dengan perawatan pada luka, stoma dan
inkontinensia berupa hasil riset, studi kasus, maupun studi literature.

Panduan:

a. Abstrak ditulis dengan jelas untuk membantu pembaca dalam memahami aspek penting dan
temuan dari hasil riset atau kajian literatur yang akan disampaikan
b. Abstrak maksimal menggunakan 300 kata
c. Abstrak terdiri dari latar belakang, tujuan, metode, hasil dan kesimpulan
d. Maksimal menggunakan 5 kata kunci
e. Kata kunci ditulis di bawah abstrak dengan dipisahkan tanda koma

Contoh abstrak

Tissue Adhesive for Wound Closure Reduces Immediate Postoperative Wound Dressing
Changes After Primary TKA

xxxx1*, yyyyy1, zzzzz1


1
Rumah Luka Surabaya vvvvvv, Indonesia
Corresponding Author: xxxxxx (xxxxx@gmail.com)

Background Prolonged wound drainage after TKA is associated with increased risk of infection. To
decrease wound drainage, tissue adhesive has been suggested as an adjunct to wound closure after
TKA; however, no studies of which we are aware have investigated the effect of tissue adhesive in a
modern fast-track TKA setting.
Purposes The purpose of this study was to evaluate the effect of wound closure using a high-viscosity
tissue adhesive in simultaneous bilateral TKA with respect to (1) postoperative wound drainage,
measured as number of dressing changes in the first 72 hours postoperatively; and (2) wound healing
assessed using the ASEPSIS score.
Methods Thirty patients undergoing simultaneous bilateral TKA were included in the study. The left
knee was randomized to receive either standard three-layer closure with staples or the same closure
supplemented with tissue adhesive with the opposite treatment used on the contralateral knee. One
patient underwent a constrained TKA and underwent revision 2 days after the index procedure and
was therefore excluded leaving 29 patients (58 knees) for analysis. Sixty-two percent (n = 18) were
female. Mean age was 64 years (range, 42-78 years). Mean body mass index was 28 kg/m2 (range,
21–38 kg/m2). Postoperative wound drainage was evaluated as drainage resulting in a dressing
change. The wound dressing was changed if it was soaked to the borders of the absorbable dressing
at any point. The nurses changing the dressing were blinded to treatment allocation up to the first
dressing change. The number of dressing changes during the first 72 hours postoperatively was
recorded. The secondary study endpoint was the ASEPSIS score, which is a clinical score assessing
wound healing. ASEPSIS score, measured by a nurse not involved in the treatment, was compared
between the groups at 3 weeks followup.
Results Knees with tissue adhesive underwent fewer dressing changes (median, 0; interquartile range
[IQR], 0-1) compared with the contralateral knee (IQR, 1-2; difference of medians, one dressing
change; p = 0.001). A total of 59% of knees in the intervention group did not undergo any dressing
changes before discharge, whereas 24% of knees in the control group did not undergo any dressing
changes before discharge (p = 0.02). The knees in the intervention group and the control group did
not differ with respect to ASEPSIS score at 3 weeks.
Conclusions Tissue adhesive as an adjunct to standard wound closure after primary TKA reduced
the number of dressing changes after surgery, but did not change the appearance or healing of the
wound at 3 weeks based on the ASEPSIS scores. Whether the small differences observed here in
terms of the number of dressing changes performed will justify the additional costs associated with
using this product or whether there are other differences associated with the use of tissue adhesive
that may prove important such as patient preferences or longer term differences in wound healing or
infection should be studied in the future.
Key words: Wound Closure, Wound Dressing, Primary TKA

Sistem Submit
Abstrak dikirim ke bagian sie ilmiah ke email: dfm.inwocna19@gmail.com dengan subject:
nama/institusi/(pilih oral atau poster presentasi) paling lambat tanggal 15 September 2019. Abstrak
yang lolos seleksi akan diberikan Letter of Acceptance (LoA) dan Letter of Invitation (LoI) untuk
dipresentasikan pada pertemuan ilmiah ini. Full paper diterima panitia paling lambat tanggal 15
Oktober 2019. Panduan penulisan full paper terlampir. Abstrak yang terpilih tetap melakukan
registrasi sesuai ketentuan dari panitia.

Panduan Penulisan Full Paper

Dilarang mengubah ukuran font, spasi dan template full paper, penulisan referensi dengan
menggunakan Vancouver.
Title title title title title title
Arum Sekarwati1*, Tomo Jerry1, Harsah2, Erfandi3

1 Siloam Hospital, Surabaya, Indonesia, 53123


2 Wound Center Madura, Bangkalan, 53123
3 RSUD dr Soetomo, Suarabaya, Indonesia, 53146

*Corresponding author : Arum Sekarwati, Jl. Dr. Yadi, Surabaya, 53123. Email: arum_muach.sh.ac.id

Abstract.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxx

Keywords: xxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxx (min 3 max 5)

Introduction xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Results and discussions
xxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Table.1 Xxxxxxxxxxxxxxxxxxxxxxx (n=…)

xxxxxxxxxxxxxxxxxxxx f %

1. xxxxx
Methods
xxxxxx xxx xxx

xxxxxxxxxxx xx xxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
2. xxxxxx

xxxxxxxxx xxx xxx


References
xxxxxxxxxxxxxx xxx xx
1.
xxxxxxxxxxxxxx xxxx xxx
6. Del Prato S, Felton AM, Munro N, Nesto R,
Zimmet P, Zinman B, et al. Improving glucose
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx management: Ten steps to get more patients
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx with type 2 diabetes to glycaemic goal. Int J Clin
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Pract. 2005;
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
7. Carolyne R, Mosha T, Nyaruhucha C. Risk
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Factors Associated with Elevated Blood Glucose
xxxxxxxx
Among Adults in Mwanza City, Tanzania *1.
2015;14(2):90–100.

8. Badedi M, Solan Y, Darraj H, Sabai A, Mahfouz


M, Alamodi S, et al. Factors Associated with
Conclusions Long-Term Control of Type 2 Diabetes Mellitus. J
Diabetes Res. 2016;2016.

9. Silva EFF, Ferreira CMM, Pinho L de, Silva EFF,


Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Ferreira CMM, Pinho L de. Risk factors and
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
complications in type 2 diabetes outpatients.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Rev Assoc Med Bras [Internet]. 2017;63(7):621–
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
7. Available from:
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
http://www.scielo.br/scielo.php?script=sci_artt
xxxxxxxx
ext&pid=S0104-
42302017000700621&lng=en&tlng=en
Conflict of Interest
10. Juarez DT, Sentell T, Tokumaru S, Goo R, Davis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx JW, Mau MM. Factors Associated With Poor
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Glycemic Control or Wide Glycemic Variability
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Among Diabetes Patients in Hawaii, 2006–2009.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Prev Chronic Dis [Internet]. 2012;9:120065.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Available from:
xxxxxxxx. http://www.cdc.gov/pcd/issues/2012/12_0065.
htm
Acknowledgements 11. Rasheed M, Islam N, Mahjabeen W. Original
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Article Factors Associated with Uncontrolled
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Type 2 Diabetes Mellitus. 2015;4(2):68–71.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 12. Sigal RJ, Armstrong MJ, Colby P, Kenny GP,
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Plotnikoff RC, Reichert SM, et al. Physical
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx activity and diabetes. Acta Biomed l’Ateneo
xxxxxxxx Parm [Internet]. 2005;76(SUPPL. 3):85–8.
Available from:
Ethical Clearance http://dx.doi.org/10.1016/j.jcjd.2013.01.018

Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 13. Suh S-H, Paik I-Y, Jacobs K. Regulation of blood


xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx glucose homeostasis during prolonged exercise.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Mol Cells. 2007;
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
14. Strizich G, Kaplan RC, González HM, Daviglus
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
ML, Giachello AL, Teng Y, et al. Glycemic control,
xxxxxxxx
cognitive function, and family support among medication adherence and glycemic control. Am
middle-aged and older Hispanics with diabetes: J Pharm Benefits. 2017;9(3):82–8.
The Hispanic Community Health Study/Study of
16. Egede LE, Gebregziabher M, Echols C, Lynch CP.
Latinos. Diabetes Res Clin Pract. 2016;117:64–
Longitudinal Effects of Medication
73.
Nonadherence on Glycemic Control. Ann
15. Mosen DM, Glauber H, Stoneburner AB, Pharmacother. 2014;
Feldstein AC. Assessing the association between

Das könnte Ihnen auch gefallen